Fig. 1From: Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control studyGrowth AND development process in six study aspects of ASQ at 6, 12 and 18 month old participants (X axis is the age of study participant and the Y axis is the ASQ score in the related area)Back to article page